
    
      The study design is a double-blind, randomized, placebo-controlled multicenter study. Liquid
      Regenexx Stem Cell Support Formula compared to placebo control administered via oral
      application for 2 months to determine effect on knee function and pain in patients with knee
      OA.

      Treatment group: Forty patients randomized to the treatment group will receive daily doses of
      stem cell support formula for 60 days. Patients will complete patient-reported outcome
      questionnaires at 1 month and 2 months.

      Control group: Forty patients randomized to the control group will receive a daily doses of
      placebo stem cell support formula for 60 days. Patients will complete patient-reported
      outcome questionnaires at 1 month and 2 months.
    
  